Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000709160 | SCV000838459 | uncertain significance | Multiple endocrine neoplasia, type 1 | 2018-07-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000709160 | SCV002196819 | uncertain significance | Multiple endocrine neoplasia, type 1 | 2025-01-17 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 137 of the MEN1 protein (p.Arg137Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of multiple endocrine neoplasia type 1 (PMID: 29497973, 35264596). ClinVar contains an entry for this variant (Variation ID: 584771). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MEN1 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |